v3.25.1
Consolidated Statements of Stockholders’ Deficit - USD ($)
$ in Thousands
Common shares
Additional Paid in capital
Accumulated other comprehensive loss
Accumulated Deficit
Total
Balance at Dec. 31, 2022 $ 1 $ 831 $ (12) $ (1,262) $ (442)
Balance (in Shares) at Dec. 31, 2022 4,311,309        
Exercise of stock options [1] 91 91
Exercise of stock options (in Shares) 628,045        
Stock-based compensation   10 10
Issuance of common stock upon conversion of loan [1] 509 509
Issuance of common stock upon conversion of loan (in Shares) 1,206,834        
Effect of reverse recapitalization [1] (24) (24)
Effect of reverse recapitalization (in Shares) 2,096,040        
Issuance of common stock in a private placement offering [1] 501 501
Issuance of common stock in a private placement offering (in Shares) 910,000        
Total comprehensive loss (15) (804) (819)
Balance at Dec. 31, 2023 $ 1 1,918 (27) (2,066) (174)
Balance (in Shares) at Dec. 31, 2023 [2] 9,152,228        
Stock-based compensation (4)   (4)
Issuance of common stock in a private placement offering [1] 410 410
Issuance of common stock in a private placement offering (in Shares) [2] 412,123        
Total comprehensive loss (3) (842) (845)
Balance at Dec. 31, 2024 $ 1 $ 2,324 $ (30) $ (2,908) $ (613)
Balance (in Shares) at Dec. 31, 2024 [2] 9,564,351        
[1] Less than $1 thousand.
[2] On August 28, 2023, the Company amended and restated its Certificate of Incorporation to effect a 1 for 150 Reverse Stock Split of its outstanding shares of common stock effective April 24, 2024. Consequently, all share numbers, share prices, and exercise prices have been retroactively adjusted in these consolidated financial statements for all periods presented.